Instalab
logoInstalab

Common Buckwheat (Fag e 2) IgE

Blood Test
A blood signal that can help separate true buckwheat allergy from quiet sensitization, alongside standard buckwheat testing.
4.9 (4,619 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Common Buckwheat (Fag e 2) IgE test?

This test is most useful if any of these apply to you.

Reacted to Buckwheat Before
You've had hives, breathing trouble, or a more severe reaction after eating buckwheat noodles, pancakes, or other buckwheat-containing foods.
Working With Buckwheat Flour
You're a cook, baker, or food handler with workplace symptoms like rhinitis, asthma, or skin reactions that flare around buckwheat exposure.
Already Have a Latex Allergy
You react to latex and want to check whether your immune system also reacts to buckwheat, since the two have been linked in some cases.
Had Anaphylaxis Without a Clear Cause
You've had a severe allergic reaction, standard food panels haven't found the trigger, and buckwheat was in something you ate.

About Common Buckwheat (Fag e 2) IgE

If you have ever reacted to buckwheat noodles, pancakes, or a pillow filled with buckwheat husks, this is one of the tests that can help tell you whether your immune system is truly primed against a clinically important protein in the seed. Buckwheat allergy is uncommon but can cause anaphylaxis, and the standard buckwheat blood test often cannot distinguish between people who genuinely react and people whose blood simply shows traces of antibodies.

This test measures Fag e 2 IgE (immunoglobulin E directed at the Fag e 2 protein in common buckwheat). Used alongside other buckwheat components, it can help separate a real food allergy from a quiet sensitization that may never cause symptoms.

What This Test Actually Measures

Fag e 2 is a small, sturdy storage protein found inside the buckwheat seed, classified as one of the major allergens in common buckwheat alongside Fag e 1 and Fag e 3. It resists being broken down by stomach acid and digestive enzymes, which is part of why it can trigger strong reactions. When your immune system mistakes Fag e 2 for a threat, it produces IgE (a class of antibody that drives allergic reactions) targeted specifically at this protein.

A blood draw measures how much of this Fag e 2-specific IgE is circulating. A positive result means your immune system has built a memory against this exact buckwheat protein. The number does not measure symptoms directly, but it reflects the underlying biology that produces them.

True Allergy vs Quiet Sensitization

One reason this test exists is to help separate two groups of people who can look identical on a standard buckwheat blood panel: those who will react clinically to buckwheat, and those whose immune system has noticed buckwheat without ever causing symptoms. In a small clinical study comparing buckwheat-allergic patients with sensitized-but-asymptomatic patients, all of the truly allergic patients had Fag e 2-specific IgE in their serum, while only a small minority of sensitized-but-asymptomatic patients did.

A positive crude buckwheat blood test can show up in many people who tolerate buckwheat just fine. Layering in Fag e 2 alongside other buckwheat components (especially Fag e 1, Fag e 3, and Fag e 5) can sharpen the picture and reduce the chances of unnecessary food avoidance.

Risk of Severe Reactions and Anaphylaxis

Sensitization to Fag e 2 is associated with severe reactions, including anaphylaxis. A pediatric study found that strong IgE binding to Fag e 2 and certain larger buckwheat proteins (in the 40 to 50 kilodalton range) tracked with moderate-to-severe symptoms in Korean children with buckwheat allergy. A separate case report of buckwheat-triggered anaphylactic shock documented elevated Fag e 2 IgE on testing.

The picture gets stronger when Fag e 2 is positive alongside two other buckwheat components, legumin (Fag e 1) and Fag e 5. Concomitant sensitization to all three was shown to predict true clinical buckwheat allergy rather than asymptomatic sensitization. Separately, a pilot study found that Fag e 3-specific IgE significantly predicted positive oral food challenge results and anaphylaxis, and recent reviews highlight Fag e 3 as a particularly useful diagnostic component. Higher specific IgE levels to a culprit food are also linked to a greater risk of anaphylaxis during supervised oral food challenges in a broad pediatric food allergy study.

Occupational Buckwheat Exposure

Cooks, bakers, and food handlers can develop buckwheat allergy through repeated workplace exposure to buckwheat flour, with reactions including allergic rhinitis, asthma, contact urticaria (hives from skin contact), and anaphylaxis. If you work with buckwheat regularly and have unexplained respiratory or skin symptoms at work, Fag e 2 IgE belongs in the workup alongside a careful occupational history and other buckwheat components.

How It Compares to Standard Buckwheat Testing

The standard buckwheat blood test (sometimes coded as f11) measures IgE against a crude extract of the whole seed. That extract contains many proteins, only some of which actually drive allergic reactions. Fag e 2 testing zooms in on a single component protein, and the numbers can add resolution to a positive extract result.

In one small study (10 allergic patients, 14 atopic dermatitis patients, 15 healthy controls), the native Fag e 2 ImmunoCAP test caught most true clinical allergies while keeping the false-positive rate low, with an AUC of 0.967 (a measure of overall test accuracy where 1.0 is perfect). Chip-based microarray versions of the same component test missed many true allergies in a separate analysis, so the assay platform matters. The evidence base for Fag e 2 testing remains limited, and combining it with other buckwheat components gives the most reliable picture.

Latex Allergy and Buckwheat

Buckwheat allergy has been described in patients with natural rubber latex allergy in case reports. Current evidence suggests the buckwheat component most likely involved in latex cross-reactivity is Fag e 4 (a hevein-like antimicrobial peptide), not Fag e 2. If you have a known latex allergy and have ever had an unexplained reaction to buckwheat, Fag e 2 testing is part of a broader buckwheat workup, but Fag e 4 testing would be more directly relevant to the latex question.

Why a Single Reading Is Not the Whole Story

A blood IgE level is one data point. It reflects your immune memory against Fag e 2 at the moment of the draw, which can shift over months and years as exposures change. For symptomatic people, retesting at intervals helps track whether sensitization is rising, falling, or stable, and whether avoidance is changing the immune picture.

There is no buckwheat-specific evidence base defining how often to retest Fag e 2 IgE. Retesting cadence is generally guided by an allergist based on your history, symptom course, and whether reintroduction is being considered, rather than a fixed schedule. If you have had a severe reaction or are considering reintroduction under medical supervision, more frequent testing alongside skin prick testing makes sense.

When Results Can Be Misleading

A few situations can complicate interpretation of a Fag e 2 IgE result:

  • Negative does not mean safe in someone who has reacted: Component-resolved studies have shown that some clinically buckwheat-allergic patients do not have detectable Fag e 2 IgE on multiplex chip platforms. If you have a clear history of reacting to buckwheat, a negative Fag e 2 does not fully rule out allergy. Other buckwheat proteins (Fag e 1, Fag e 3, Fag e 5) can drive symptoms, and Fag e 3 in particular has been highlighted as diagnostically useful in recent literature.
  • Positive does not always mean you will react: IgE shows sensitization, not certainty of clinical symptoms. Oral food challenge remains the gold standard for confirming food allergy when results are ambiguous.
  • Assay platform matters: The same biomarker tested on a microarray chip can return very different results than on a native protein ImmunoCAP assay. The chip version missed a substantial share of true allergies in a comparison study.
  • Standard panels often skip it: In a large atopic dermatitis cohort tested with a broad multiplex panel, no patients had detectable IgE to Fag e 2. Many routine allergy panels do not include this component, so a clean standard panel does not mean buckwheat has been ruled out.

What to Do With an Unexpected Result

If your Fag e 2 IgE is positive and you have a history of reactions, this is supportive evidence of true buckwheat allergy. The next step is usually an allergist consultation to confirm the picture, often with skin prick testing to buckwheat extract and additional component testing (Fag e 1, Fag e 3, Fag e 5), and to plan avoidance, epinephrine prescription, and possibly supervised oral food challenge if the situation is ambiguous.

If your Fag e 2 IgE is positive but you have never had symptoms, do not assume the worst. Sensitization without clinical reactions is well documented in the buckwheat literature. An allergist can interpret the number alongside skin prick testing and other buckwheat components to clarify whether real-world avoidance is warranted.

If your Fag e 2 IgE is negative but you have had a clear buckwheat reaction, ask about testing other buckwheat components (Fag e 3 in particular has emerging diagnostic value) and consider a skin prick test, which one study found more useful than extract-based blood IgE for predicting positive food challenge outcomes.

Frequently Asked Questions

Panels containing Common Buckwheat (Fag e 2) IgE

Common Buckwheat (Fag e 2) IgE is included in these pre-built panels.

References

16 studies
  1. Cho J, Lee J, Choi J, Park MR, Shon D, Kim J, Ahn K, Han YAllergy, Asthma & Immunology Research2015
  2. Geiselhart S, Nagl C, Dubiela P, Pedersen AC, Bublin M, Radauer C, Bindslev-jensen C, Hoffmann-sommergruber K, Mortz CClinical and Experimental Allergy2017
  3. Tohgi K, Kohno K, Takahashi H, Matsuo H, Nakayama S, Morita EArchives of Dermatological Research2011
  4. Kajita N, Yoshida KCurrent Allergy and Asthma Reports2024